FDA Warning Letter — Smitha Reddy, M.D.
The FDA took a Warning Letter action against Smitha Reddy, M.D. on June 3, 2022 (Poway, CA). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Smitha Reddy, M.D.
- Date
- June 3, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Center
- CDER
- Location
- Poway, CA (United States)